BR0110845A - Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas - Google Patents

Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas

Info

Publication number
BR0110845A
BR0110845A BR0110845-0A BR0110845A BR0110845A BR 0110845 A BR0110845 A BR 0110845A BR 0110845 A BR0110845 A BR 0110845A BR 0110845 A BR0110845 A BR 0110845A
Authority
BR
Brazil
Prior art keywords
allergic diseases
treatment
aniline
disulfide derivatives
preventing
Prior art date
Application number
BR0110845-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Mark R Hellberg
Zixia Feng
Steven T Miller
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0110845A publication Critical patent/BR0110845A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR0110845-0A 2000-05-19 2001-04-25 Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas BR0110845A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20574600P 2000-05-19 2000-05-19
PCT/US2001/013242 WO2001090059A1 (en) 2000-05-19 2001-04-25 Aniline disulfide derivatives for treating allergic diseases

Publications (1)

Publication Number Publication Date
BR0110845A true BR0110845A (pt) 2003-02-11

Family

ID=22763478

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110845-0A BR0110845A (pt) 2000-05-19 2001-04-25 Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas

Country Status (19)

Country Link
US (2) US6372802B2 (enExample)
EP (1) EP1289945B1 (enExample)
JP (1) JP2003534317A (enExample)
KR (1) KR20020093982A (enExample)
CN (1) CN1173697C (enExample)
AR (1) AR028565A1 (enExample)
AT (1) ATE272619T1 (enExample)
AU (2) AU2001257227B2 (enExample)
BR (1) BR0110845A (enExample)
CA (1) CA2408145A1 (enExample)
DE (1) DE60104690T2 (enExample)
DK (1) DK1289945T3 (enExample)
ES (1) ES2222370T3 (enExample)
MX (1) MXPA02011480A (enExample)
PL (1) PL365459A1 (enExample)
PT (1) PT1289945E (enExample)
TR (1) TR200402299T4 (enExample)
WO (1) WO2001090059A1 (enExample)
ZA (1) ZA200208839B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
WO2006076027A2 (en) * 2004-05-17 2006-07-20 Cambrios Technology Corp. Biofabrication of transistors including field effect transistors
KR20070024618A (ko) * 2004-06-28 2007-03-02 알콘, 인코퍼레이티드 알레르기성 질환 치료용 국소 제제
US20130304180A1 (en) * 2012-05-09 2013-11-14 Michael L. Green Catheter having dual balloon hydraulic actuator
US11058444B2 (en) 2017-12-11 2021-07-13 Covidien Lp Electrically enhanced retrieval of material from vessel lumens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (enExample) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0062827B1 (en) 1978-06-16 1986-07-23 Kyowa Hakko Kogyo Co., Ltd Novel benzamide derivatives
JPS59205356A (ja) * 1983-05-10 1984-11-20 Teikoku Hormone Mfg Co Ltd ジスルフアニルベンゼン酢酸誘導体
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH08253454A (ja) * 1994-12-26 1996-10-01 Nisshin Flour Milling Co Ltd ジフェニルジスルフィド化合物
JPH095926A (ja) 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
WO1997038693A1 (en) 1996-04-18 1997-10-23 Alcon Laboratories, Inc. Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
JP2894445B2 (ja) * 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸
JP3702382B2 (ja) * 1997-10-22 2005-10-05 参天製薬株式会社 ＮＦ−κＢ活性化阻害剤
AU5567501A (en) * 2000-05-19 2001-12-03 Alcon Universal Ltd Disulfide derivatives useful for treating allergic diseases
AU5380701A (en) * 2000-05-19 2001-12-03 Alcon Universal Ltd Compositions containing a benzamide disulfide derivative for treating allergic diseases
JP2002193796A (ja) * 2000-12-27 2002-07-10 Ajinomoto Co Inc 炎症因子活性化抑制剤、その用途及びそのために使用可能な新規ポリスルフィド誘導体

Also Published As

Publication number Publication date
PL365459A1 (en) 2005-01-10
ZA200208839B (en) 2004-02-03
DK1289945T3 (da) 2004-11-01
AU5722701A (en) 2001-12-03
ES2222370T3 (es) 2005-02-01
US6452052B1 (en) 2002-09-17
ATE272619T1 (de) 2004-08-15
US20020115658A1 (en) 2002-08-22
CA2408145A1 (en) 2001-11-29
WO2001090059A1 (en) 2001-11-29
JP2003534317A (ja) 2003-11-18
DE60104690D1 (de) 2004-09-09
MXPA02011480A (es) 2003-06-06
AR028565A1 (es) 2003-05-14
KR20020093982A (ko) 2002-12-16
CN1429208A (zh) 2003-07-09
EP1289945B1 (en) 2004-08-04
AU2001257227B2 (en) 2005-04-07
TR200402299T4 (tr) 2004-12-21
US6372802B2 (en) 2002-04-16
PT1289945E (pt) 2004-10-29
US20020013311A1 (en) 2002-01-31
HK1050677A1 (en) 2003-07-04
DE60104690T2 (de) 2005-01-13
EP1289945A1 (en) 2003-03-12
CN1173697C (zh) 2004-11-03

Similar Documents

Publication Publication Date Title
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
BR0317104A (pt) Composições farmacêuticas dispersáveis
BRPI0412581A (pt) formulação dispersável de um agente antiinflamatório
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
BR0210707A (pt) Formulações de olopatadina para administração tópica
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
UA107653C2 (en) Extract of aerial parts of oats harvested before ear emergence
SE0100158D0 (sv) Novel method and composition for local treatment of Meniere´s disease and tinnitus
NO20075354L (no) Forbindelser, isomerer og farmasoytiske akseptable salter derav, som vanilloidreseptorantagoniser, og farmasoytiske preparater inneholdende slike
BRPI0414320A (pt) composição para tratamento da pele
BRPI0812494A2 (pt) Derivados de 3',4',5-trimetóxi como estimulante da secreção de muco, método de preparação do mesmo, e composição farmacêutica compreendendo o mesmo
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BR0312696A (pt) Tratamento tópico de doenças da pele
EA200702204A1 (ru) Лечение заболеваний соединительной ткани кожи
WO2005053719A3 (en) Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
WO2006034048A8 (en) Therapeutic agents targeting the ncca-atp channel and methods of use thereof
BR0110845A (pt) Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas
PT2465493E (pt) Composições tópicas para a prevenção e tratamento da irritação das células mucosas
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.
DE602006008186D1 (de) Neues imprägnierverfahren einer textiloberfläche
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
BR0110852A (pt) Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas
BR0110943A (pt) Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.